We showed that in tumor tissues Losartan decreased thiol concentrations and catalase activity, two anti-oxidant markers (Figure 5A and B(Fig. 5)), and increased MDA level and ROS generation, biomarkers of oxidative stress (Figure 5C and D(Fig. 5)). The gene discussed is CAT; the disease is neoplasm.